Hormone therapy in an elderly transsexual woman: a case study

Authors

DOI:

https://doi.org/10.33448/rsd-v11i10.33113

Keywords:

Elderly transsexualism; Health; Women's health; Hormone replacement therapy.

Abstract

Objective: to present and describe the result of cross-hormonal therapy in a transsexual woman treated at a specialized center in the State of Rio de Janeiro. Methodology: A case study carried out from June 2022 onwards, with a transsexual individual treated at the single-gender identity outpatient clinic of a public health institution, which performs multidisciplinary follow-up of cross hormone therapy. Results: The elderly transsexual has risk behaviors, health risk use and quality of life. The user possibly presented several comorbidities, but there is no way to categorically state the relationship with its use or self-medication, as the aging process also contributes to the development of diseases. Final considerations: You must accompany the consultations, collaborating with your expertise, in the early detection of diseases and estimates that should evaluate the hormonalization process. They should also promote and encourage habits in order to minimize the increase in aging and therapy changes, as well as improve their quality of life.

References

Åberg, F., Puukka, P., Salomaa, V., Männistö, S., Lundqvist, A., Valsta, L., Perola, M., Färkkilä, M., &Jula, A. (2020). Risks of light and moderate alcohol use In fatty liver disease: follow-up of population cohorts. Hepatology, 71(3), 835–848. Https://Doi.Org/10.1002/Hep.30864

Brasil, M. Da C. C. (2003). Lei n 10.741, de 1 de outubro de 2003. Estatuto do idoso. https://bvsms.saude.gov.br/bvs/saudelegis/gm/2013/prt2803_19_11_2013.html

Brasil, M. Da S. (2013). Portaria no 2.803, de 19 de novembro de 2013.redefine e amplia o processo transexualizador no sistema único de saúde (SUS). https://bvsms.saude.gov.br/bvs/saudelegis/gm/2013/prt2803_19_11_2013.html

Carballo, G. O., Domínguez, E. A., Alzugaray, M. G., &Cazeres, E. D. (2019). Hormonal treatment and complications in patients withgender dysphoria. Revista Cubana De Endocrinología, 30(2), 1–10.

Cheded, M., & Liu, C. (2022). “Qual parte do dia é (mulher) hora?”: Desejos, impulsos e possibilidades de (des)tornar-se. Marketing Theory, 22(1), 67–84. https://doi.org/10.1177/14705931211057463

Coimbra, M. de N. C. T., & Martins, A. M. de O. (2013). O estudo de caso como abordagem metodológica no ensino superior. Nuances: Estudos sobre educação, 24(3), 31–46. https://doi.org/10.14572/nuances.v24i3.2696

De Souza, K. A. (2020). Transexualidade – Transfobia e misoginia: espaços que produzem e reproduzem a transfobia intrafamiliar – institucional e social. 12.

Haupt, C., Henke, M., Kutschmar, A., Hauser, B., Baldinger, S., Saenz, S. R., &Schreiber, G. (2020). Antiandrogenor estradiol treatment orbothduring hormone therapy in transitioning transgender women. Cochrane Database Of Systematic Reviews, 11, article 11. https://doi.org/10.1002/14651858.cd013138.pub2

Janini, J. P., & Migowski, L. (2021a). Câncer em neovagina de mulheres trans: Uma revisão sistemática. Research, Society And Development, 10(12), e346101220584–e346101220584. https://doi.org/10.33448/rsd-v10i12.20584

Jones, A. R., Herath, M., Ebeling, P. R., Teede, H., &Vincent, A. J. (2021). Models Ofcare For Osteoporosis: A systematicscoping review ofefficacy andimplementation characteristics. E Clinical Medicine, 38, 101022. https://doi.org/10.1016/j.eclinm.2021.101022

Junior, S. A. P., Oliveira, R. R., Lima, B. S., Barros, R. F. De, Alves, V. R. S., Silva, F. J. Da, & Sousa, A. B. Do N. (2022). Combate à hipertensão arterial: Importância da prevenção e do cuidado. Research, Society And Development, 11(4), e56211427794–e56211427794. https://doi.org/10.33448/rsd-v11i4.27794

Kanwal, F., Shubrook, J. H., Adams, L. A., Pfotenhauer, K., Wai-Sunwong, V., Wright, E., Abdelmalek, M. F., Harrison, S. A., Loomba, R., Mantzoros, C. S., Bugianesi, E., Eckel, R. H., Kaplan, L. M., El-Serag, H. B., &Cusi, K. (2021). Clinical carepathway for therisks tratification and management of patientswithnonalcoholicfattyliver disease. Gastroenterology, 161(5), 1657–1669. https://doi.org/10.1053/j.gastro.2021.07.049

Matos, T. C. (2021). Disforia de género: Revisão do tratamento hormonal. Disforia de género: Revisão do tratamento hormonal, 53.

Mott, T., Latimer, K., & Edwards, C. (2018). Hemorrhoids:diagnosis and treatment options. American Family Physician, 97(3), 172–179.

Radix, A., Sevelius, J., & Deutsch, M. B. (2016). Transgender women, Hormonal Therapy and hivtreatment: A Comprehensive review ofthe literature and recommendations for Best practices. Journal Of The International Aids Society, 19(3s2), 20810. https://doi.org/10.7448/ias.19.3.20810

Rajendram, R., & Preedy, V. R. (2009). 41 - Ethanol in Beer: Production, Absorption and Metabolism. Em V. R. Preedy (Org.), Beer in Health and Disease Prevention (p. 431–440). Academic Press. https://doi.org/10.1016/B978-0-12-373891-2.00041-9

Ramalheira, R. A. F. (2017). Fármacos antitiroideus e hormonas tiroideias – Perfil de utilização, efeitos secundários e interações medicamentosas. https://ubibliorum.ubi.pt/handle/10400.6/8315

Ribeiro, P. V. S. (2020). Terapia hormonal para redesignação de gênero- Mulher trans: Uma revisão. Saúde.Com-Ciência Issn: 2594-5890, 1, 9–16.

Safer, J. D., & Tangpricha, V. (2019). Care of transgender persons. New England Journal Of Medicine, 381(25), 2451–2460. https://doi.org/10.1056/nejmcp1903650

Silva, F. G. De O., Peixoto, D. L. C., Narciso, T. Da S., Neto, F. G. De C., & Lima, L. R. (2017). Cuidado farmacêutico ao paciente portador de doença hepática gordurosa não alcoólica. Mostra científica da farmácia, 3(1), article 1. http://publicacoesacademicas.unicatolicaquixada.edu.br/index.php/mostracientificafarmacia/article/view/1230

Spanos, C., Bretherton, I., Zajac, J. D., & Cheung, A. S. (2020). Effects of gender-affirming hormone therapy oninsulin resistance and Body Composition In Transgender individuals: A Systematic Review. World Journal Of Diabetes, 11(3), 66–77. https://doi.org/10.4239/wjd.v11.i3.66

Stinchcombe, A., Smallbone, J., Wilson, K., & Kortes-Miller, K. (2017). Health care andend-of-life needs of lesbian, gay, bisexual, and transgender (lgbt) olderadults: A scoping review. Geriatrics, 2(1), 13.

Sttela, F. P. P., & Jaise, F. S. (2019). Perfil dos pacientes idosos polimedicados e os seus regimes farmacoterapêuticos. Conhecendo Online, 5(1), 86–107.

Takahashi, A. R. W., & Araujo, L. (2020). Case Study research: Openingupre search opportunities. Rausp Management Journal, 55, 100–111. https://doi.org/10.1108/rausp-05-2019-0109

Tebbens, M., Heijboer, A. C., T’sjoen, G., Bisschop, P. H., & Denheijer, M. (2022). The role ofestrone in feminizing hormone treatment. The Journal Of Clinical Endocrinology & Metabolism, 107(2), E458–E466.

Urbaniak, A., Jablonska, K., Podhorska-Okolow, M., Ugorski, M., &Dziegiel, P. (2018). prolactin-inducedprotein (pip)-characterization and role in breastcancer progression. American Journal Of Cancer Research, 8(11), 2150–2164.

Verroken, C., Collet, S., Lapauw, B., & T’sjoen, G. (2022). osteoporosis and bone health in transgender individuals. calcifiedtissue international, 110(5), 615–623. https://doi.org/10.1007/s00223-022-00972-2

World Professional Association For Transgender Health. (2012). The world professional association for transgender health promotest hehighest standards ofhealth care for individual sthrough the articulation of standards ofcare (soc) for the health of transsexual, transgender, and gendernonconforming people (7oed). World Professional Association For Transgender Health. https://www.wpath.org/publications/soc

Zhang, Y., Wang, H., &Xiao, H (2021). Metformin action sontheliver: Protection mechanisms emerging in hepatocytes and immune cells against NASH-Related HCC. International Journal Of Molecular Sciences, 22(9), 5016. https://doi.org/10.3390/ijms22095016

Published

10/08/2022

How to Cite

JANINI, J. P.; OLIVEIRA , . L. C. S. de .; SOUZA, V. de M. . Hormone therapy in an elderly transsexual woman: a case study. Research, Society and Development, [S. l.], v. 11, n. 10, p. e550111033113, 2022. DOI: 10.33448/rsd-v11i10.33113. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/33113. Acesso em: 4 oct. 2022.

Issue

Section

Health Sciences